Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 27.10.2021.

#financing
#breastcancer
#oncology
#biotech
#climatechange
#GoodDayBIO
#WorldPolioDay
#CRISPR

Startups

@Forbes shared
On Oct 26, 2021
RT @alexrkonrad: Y Combinator has named the first biotech and healthcare focused partner in its history, tapping former nVision Medical founder Surbhi Sarna. I spoke to the storied accelerator about how its bio push requires a new playbook — literally. https://t.co/8B1EXYsdyO
Open
Y Combinator Names Surbhi Sarna Its First-Ever Partner For Healthcare And Biotech

Y Combinator Names Surbhi Sarna Its First-Ever Partner For Healthcare And Biotech

Subhi Sarna sold nVision Medical for $275 million in 2018. Now she's been named Y Combinator's first-ever group partner focused on healthcare and biotech as part of a pandemic-fueled deeper ...

@big4bio shared
On Oct 26, 2021
Cedilla Therapeutics, an #oncology #biotech, has snagged an additional $25M to bring two small-molecule oncology programs into human trials. This #financing adds to the $57.6M already raised in Series B funds last year. #breastcancer Read more here: https://t.co/VSpodc4tRO
Open
Cedilla tops off series B with additional $25M to test drugs in mesothelioma, certain breast cancers

Cedilla tops off series B with additional $25M to test drugs in mesothelioma, certain breast cancers

Cedilla Therapeutics added $25 million to its 2020 series B to bring two lead programs into the clinic next year. One goes after mesothelioma and certain squamous cell carcinomas, and the ...

@BusinessInsider shared
On Oct 25, 2021
EXCLUSIVE: Rising biotech Cellino is raising $75 million to to make it easier to produce stem cells with AI https://t.co/HXB8hY5Ugc
Open
EXCLUSIVE: Rising biotech Cellino is raising $75 million to make it easier to produce stem cells with AI

EXCLUSIVE: Rising biotech Cellino is raising $75 million to make it easier to produce stem cells with AI

Cellino uses AI to make therapeutic stem cells faster. Sources told Insider it's raising at least $75 million in new funding.

@IAmBiotech shared
On Oct 22, 2021
#GoodDayBIO: Reports from the intelligence community about the impact of #climatechange on global security—and the role for biotechnology. Sunday’s #WorldPolioDay, so we also look at the history of the vaccine and the latest news from Afghanistan. https://t.co/21Ggeg0U3r
Open
Good Day BIO: Intelligence community warns climate change threatens security – biotech can help.

Good Day BIO: Intelligence community warns climate change threatens security – biotech can help.

Ending the week with alarming reports from the intelligence community about the impact of climate change on global security—and the role for biotechnology. Sunday’s World Polio Day, so we ...

@FierceBiotech shared
On Oct 21, 2021
ReCode's CF program uses nonviral lipid nanoparticles to deliver mRNA that aim to restore function of the cystic fibrosis transmembrane conductance regulator https://t.co/gSrutIFjQF
Open
Another $80M: mRNA biotech ReCode matches 2020 series A with Pfizer, Sanofi money for cystic fibrosis trial

Another $80M: mRNA biotech ReCode matches 2020 series A with Pfizer, Sanofi money for cystic fibrosis trial

ReCode Therapeutics is back with its second $80 million financing round, this time a series B from Pfizer, Sanofi and VC shops, to bring its lead programs into human trials. Up first are ...

@BentheFidler shared
On Oct 26, 2021
Vertex aligns with another #CRISPR gene editing startup https://t.co/OAj8dDLNn6 $VRTX $CRSP @mammothbiosci
Open
Vertex aligns with another CRISPR gene editing startup

Vertex aligns with another CRISPR gene editing startup

A new alliance with Mammoth Biosciences marks the latest evidence of Vertex's interest in gene editing, which has already been the focus of multiple deals with emerging biotechs. 

@GENbio shared
On Oct 22, 2021
DNA Writing Progress Presented at GP-Write's Annual Conference Genome Project-write (GP-write) gathers leading synthetic biologists and geneticists from around the globe for its annual conference held in October. Learn more: https://t.co/zqoC0nLr4e https://t.co/X6xfiLvAxg
Open
DNA Writing Progress Presented at GP-Write’s Annual Conference

DNA Writing Progress Presented at GP-Write’s Annual Conference

Genome Project-write (GP-write) gathers leading synthetic biologists and geneticists from around the globe for its annual conference held in October.

@Forbes shared
On Oct 26, 2021
Mammoth Biosciences Inks $691 Million Deal To Develop Crispr Gene-Editing Therapies https://t.co/h9WcmlXLaO https://t.co/td8eg8UeK4
Open
Mammoth Biosciences Inks $691 Million Deal With Vertex For Crispr Gene-Editing Therapies

Mammoth Biosciences Inks $691 Million Deal With Vertex For Crispr Gene-Editing Therapies

The deal will see Mammoth partner with Vertex Pharmaceuticals to develop gene-editing therapies to be delivered directly into the body.

Read more: Startups
weekly 27.10.2021
View archives
Back to home

Subscribe to Biotech Essentials - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Startups.
Privacy Policy

Sign up for the weekly Biotech Essentials - Startups newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy